Side by side: size, value over time, results, valuation, margins, growth, debt and shareholder returns, and any of thirty figures charted over the years (up to 6).
Open these as a peer group: up to 12 companies with suggested peers, each company's rank in the group and percentile in its sector and country, saved for you or your team.
Free cash flow as a share of revenue. US dollars at each year's exchange rate.
Fewer than two years of free cash flow margin are on file for these companies.
| Measure | Celcuity Inc.✕ CELC · #4,529 in the world |
|---|---|
| Profile | |
| Country | 🇺🇸 USA |
| Sector | Healthcare |
| Industry | Diagnostics and Research |
| Founded | 2011 |
| Size | |
| Market cap | $3.5 B |
| Net income | $-177 M |
| Employees | |
The largest companies, each against its nearest peers in value from the same industry.
| 155 |
| Valuation | |
|---|---|
| Price to book | 35.2× |
| Free cash flow yield | -4.3% |
| Profitability | |
|---|---|
| Return on equity | -163.8% |
| Financial strength | |
|---|---|
| Debt to equity | 1.4× |
| Interest cover | -12.0× |
| Altman Z-score zone | — |
|---|
| Data as of | Market cap Oct 2026; ratios FY2025 |
|---|
Market caps from exchange data or SEC filings on the date shown (* last known value, no current one); revenue and net income from the latest annual results; ratios worked out from each company's own statements for the fiscal year shown. ▲ marks the best of these companies where higher or lower is better; size and valuation multiples are marked for no one. Definitions: methodology.